Your Search Results

Vulnerable plaque PCI after PREVENT

22 May 2025 – From EuroPCR 2025

This interview with Michael Haude and Thomas Cuisset explores findings from the PREVENT trial, which included over 1,600 patients with vulnerable, physiologically non-significant plaques identified by IVUS.

Patients were randomised to optimal medical therapy (OMT) alone or OMT plus preventive PCI. While the composite endpoint favoured the PCI...

What are the essentials of the provisional strategy for non-left main true bifurcation lesions?

21 May 2025 – From EuroPCR 2025

Giuseppe Di Gioia and Jens Flensted Lassen explore the essentials of the provisional stenting strategy for non-left main true bifurcation lesions. This stepwise approach offers simplicity while preserving flexibility: start with one stent in the main vessel, and keep the option open for a second if...

What are the essentials of the provisional strategy for non-left main true bifurcation lesions?

Hotline - ACURATE neo2 under-expansion in the ACURATE IDE study: a post-hoc analysis

21 May 2025 – From EuroPCR 2025

Howard Herrmann and Raj Makkar discuss a sub-study of the ACURATE IDE trial, which examined valve under-expansion detected by fluoroscopy. Among 1,500 patients with aortic stenosis, 22 % of ACURATE neo2 valves showed under-expansion, often linked to heavy valve calcification.

Patients with under-expanded valves faced higher risks...

ACURATE neo2 under-expansion in the ACURATE IDE study: a post-hoc analysis

How will EARLY-TAVI and NOTION-3 impact TAVI practice?

21 May 2025 – From EuroPCR 2025

When is the right time to perform TAVI—and how should coexisting coronary artery disease be managed? In this interview, Liesbeth Rosseel, Davide Capodanno, and Michael Joner tackle these two timely questions. They share key takeaways from the EARLY-TAVI trial, which demonstrated reduced rehospitalisation with early intervention...

How will EARLY-TAVI and NOTION-3 impact TAVI practice?

How to successfully approach calcified bifurcation lesions?

20 May 2025 – From EuroPCR 2025

Calcified bifurcation lesions remain one of the toughest challenges in interventional cardiology, combining two high-risk features into one complex scenario.

In this discussion, Dejan Milasinovic, Miroslaw Ferenc, and Mohamed Abdel Wahab explain why this subset deserves dedicated attention. They highlight the critical role of intra-coronary imaging to...

How to successfully approach calcified bifurcation lesions?

How to successfully approach CTO interventions: a step-by-step approach

20 May 2025 – From EuroPCR 2025

Elliot Smith, Thomas Hovasse and Roberto Garbo discuss a comprehensive, step-by-step approach to CTO interventions, providing structured guidance on navigating CTOs in a safe and effective way.

The discussion begins with angiographic assessment, emphasising the importance of identifying key anatomical features upfront. Based on this evaluation, operators determine...

How to successfully approach CTO interventions: a step-by-step approach

Early treatment of severe aortic stenosis: do we need to wait?

20 May 2025 – From EuroPCR 2025

Rahul Sharma and Darren Walters share their perspectives on shifting treatment strategies for aortic stenosis (AS), with a focus on early intervention.

Their conversation draws on the EARLY TAVR trial, which compared transcatheter aortic valve replacement (TAVR) to clinical surveillance in patients with severe, asymptomatic AS at low surgical...

Early treatment of severe aortic stenosis: do we need to wait?

PCR Tricuspid Focus Group - referral meeting in Milan

10 Jul 2023

Join your peers for this meeting on 13-14 January 2025 in Milan, Italy!

PCR Tricuspid Focus Group - referral meeting in London

21 Mar 2023

Join your peers for this meeting on 10 January 2025 in London, United Kingdom!

PCR Tricuspid Focus Group - referral meeting in Utrecht

23 Nov 2023

Join your peers for this meeting on 22 January 2025 in Utrecht, Netherlands!

Discover all about the Best personalised vascular care project Award

The winner will receive 30,000€ from Abbott during EuroPCR 2026 – the world-leading Course in interventional cardiovascular medicine

What do people think?

Discover the impact #EuroPCR has on participants. From educational content to networking and innovative techniques, read their testimonial stories and opinions